Changing aspirin use in patients with Type 2 diabetes in the UKPDS

Diabetic Medicine

Volumn 21, Issue 12, 2004, Pages 1368-1371

  Cull, Carole A ^a,c   Neil, H A W ^b   Holman, R R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Aspirin; Cardiovascular disease; Type 2 diabetes; UKPDS

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG USE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK FACTOR; SECONDARY PREVENTION;

AGE DISTRIBUTION; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; SEX DISTRIBUTION;

EID: 10244255043     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01328.x     Document Type: Article

References (9)

1. Antiplatelets Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 307: 81-106.
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
3. American Diabetes Association. Clinical practice recommendations 1997. Diabetes Care 1997; 20: S1-S70.
4. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80: S1-S29.
5. Rolka DB, Fargot-Campangna A, Venkat Narayan KM. Aspirin use among adults with diabetes. Diabetes Care 2001; 24: 197-201.
6. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
7. UKPDS Group. UK. Prospective Diabetes Study XI. Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 1994; 11: 534-544.
8. ETDRS Research Group. Aspirin effects on mortality in patients with diabetes mellitus. JAMA 1992; 268: 1292-1300.
9. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89-95.